High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$2.0M
$1,999,995
Total Sells (Filtered)
$292K
$292,776
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KYTX
P
Kyverna Therapeutics, Inc.
SEIDENBERG BETH C
• Director
Discretionary BuyΔOwn +18.1%
2025-12-18
$999,998
|
||||||
| KYTX |
Kyverna Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +18.1%
|
2025-12-18 | $999,998 | P | Form 4 |
|
KYTX
P
Kyverna Therapeutics, Inc.
Westlake BioPartners Opportunity Fund I, L.P.
• 10% Owner
Discretionary BuyΔOwn +18.1%
2025-12-18
$999,998
|
||||||
| KYTX |
Kyverna Therapeutics, Inc.
|
10% Owner
Discretionary BuyΔOwn +18.1%
|
2025-12-18 | $999,998 | P | Form 4 |
| KYTX |
Kyverna Therapeutics, Inc.
|
CTO
Other
|
2025-12-15 | $115,910 | M | Form 4 |
|
KYTX
S
Kyverna Therapeutics, Inc.
Walker Karen Marie
• CTO
10b5-1 SellΔOwn -51.5%
2025-12-15
$292,776
|
||||||
| KYTX |
Kyverna Therapeutics, Inc.
|
CTO
10b5-1 SellΔOwn -51.5%
|
2025-12-15 | $292,776 | S | Form 4 |
| KYTX |
Kyverna Therapeutics, Inc.
|
CTO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |